Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to … – SYS-CON Media (press release)
|
Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to …
SYS-CON Media (press release) HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ — Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney … |
